-+ 0.00%
-+ 0.00%
-+ 0.00%

OCULIS SIGNS ASSET PURCHASE AGREEMENT WITH ACCURE THERAPEUTICS FOR LEAD CANDIDATE, PRIVOSEGTOR, FORTIFYING OCULIS’ POSITION AS AN EMERGING LEADING NEURO-OPHTHALMOLOGY COMPANY

Reuters·08/10/2026 07:30:00

Please log in to view news